Skip to main content

Megna Michael R's Form 4 filing

Kiniksa Pharmaceuticals International, plc (KNSA) · filed Sep 3, 2026

Accession no.
0001464583-26-000008
Filed
Sep 3, 2026, 4:40 PM ET
Trade date
Jul 15-Sep 3, 2026
Filing delay
50 daysLate
Rule 10b5-1 plan
Checked

This filing lists 7 non-derivative transactions and 6 derivative transactions. Open-market sales total $369.4K. It was filed 50 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Megna Michael RCIK 0001464583Officer (CHIEF ACCOUNTING OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 15, 2026Class A Ordinary ShareAGrant or awardAcquired+279$33.50+$9,346.527,697Direct
Sep 1, 2026Class A Ordinary ShareMOption exerciseAcquired+3,932––31,629Direct
Sep 1, 2026Class A Ordinary ShareMOption exerciseAcquired+2,558––34,187Direct
Sep 1, 2026Class A Ordinary ShareMOption exerciseAcquired+2,362––36,549Direct
Sep 1, 2026Class A Ordinary ShareMOption exerciseAcquired+2,644––39,193Direct
Sep 1, 2026Class A Ordinary ShareFTax withholdingDisposed−5,531$79.28−$438,497.6833,662Direct
Sep 3, 2026Class A Ordinary ShareSSaleDisposed−4,600$80.30−$369,38029,062Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2026Class A Ordinary ShareAGrant or awardAcquired+3,650$0.00$03,650Direct
Sep 1, 2026Class A Ordinary ShareAGrant or awardAcquired+14,600$0.00$014,600Direct
Sep 1, 2026Class A Ordinary ShareMOption exerciseDisposed−2,644$0.00$07,931Direct
Sep 1, 2026Class A Ordinary ShareMOption exerciseDisposed−2,362$0.00$04,725Direct
Sep 1, 2026Class A Ordinary ShareMOption exerciseDisposed−2,558$0.00$02,557Direct
Sep 1, 2026Class A Ordinary ShareMOption exerciseDisposed−3,932$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)